Ç×ü À§Å¹»ý»ê ½ÃÀå : ¾÷°è µ¿Çâ°ú ¼¼°è ¿¹Ãø(-2035³â) - Á¦Á¶µÇ´Â Ç×ü À¯Çüº°, »ç¿ëµÇ´Â ¹ßÇö ½Ã½ºÅÛ À¯Çüº°, »ç¾÷ ±Ô¸ðº°, Áö¿ªº°
Antibody Contract Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Antibody Manufactured, Type of Expression System Used, Scale of Operation, and Geographical Regions
»óǰÄÚµå : 1821506
¸®¼­Ä¡»ç : Roots Analysis
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 321 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,799 £Ü 6,800,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,999 £Ü 9,918,000
PDF (One-Location Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ Æ¯Á¤ »ç¾÷ ºÎ¹®¿¡ ¼ÓÇÑ ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,599 £Ü 15,019,000
PDF (Department License) help
PDF º¸°í¼­¸¦ ºÎ¼­ ´ÜÀ§·Î 12¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,999 £Ü 25,506,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Ç×ü À§Å¹»ý»ê ½ÃÀå : °³¿ä

¼¼°è Ç×ü À§Å¹»ý»ê ½ÃÀå ±Ô¸ð´Â 2035³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 9.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÇ¾î ÇöÀç 185¾ï ´Þ·¯¿¡¼­ 2035³â±îÁö 468¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­¿¡¼­´Â ½ÃÀå ±Ô¸ð ¹× ±âȸ ºÐ¼®À» ´ÙÀ½°ú °°Àº ¸Å°³ º¯¼ö·Î ±¸ºÐÇÕ´Ï´Ù.

»ý»êµÇ´Â Ç×ü À¯Çü

»ç¿ëµÇ´Â ¹ßÇö ½Ã½ºÅÛ À¯Çü

»ç¾÷ ±Ô¸ð

Áö¿ª

Ç×ü À§Å¹»ý»ê ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Ç×ü´Â ´Ù¾çÇÑ »ý¹°ÇÐÀû Á¦Á¦ Áß °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â ¾à¹°±º Áß ÇϳªÀÔ´Ï´Ù. ¼ö³â¿¡ °ÉÃÄ °³³ä ¹× ¹æ¹ý·ÐÀÌ ÁøÈ­Çϸ鼭 Á¡Á¡ ´õ º¹ÀâÇϰí È¿´ÉÀÌ ³ôÀº Ç×ü ±â¹Ý Ä¡·áÁ¦ÀÇ °³¹ß ¹× Á¦Á¶¿¡ ÀÖ¾î ¸î °¡Áö Çõ½ÅÀûÀÎ ¹ßÀüÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. ¹ÙÀÌ¿À ÀǾàǰÀº Å« ÀÌÀÍÀ» °¡Á®´ÙÁÖ°í ¼ö¸¹Àº Áúº´ Ä¡·á¿¡ È¿°úÀûÀÓÀÌ ÀÔÁõµÇ¾úÀ½¿¡µµ ºÒ±¸Çϰí, ÀÌ·¯ÇÑ Ä¡·á Á¦Ç°Àº ÀϹÝÀûÀ¸·Î °³¹ß ºñ¿ëÀÌ ³ô°í Á¦Á¶ ÇÁ·ÎÅäÄÝÀÌ º¹ÀâÇÑ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.

ÃÖ±Ù ¸î ³â µ¿¾È À§Å¹»ý»ê¾÷ü´Â Àüü ¹ÙÀÌ¿ÀÀǾàǰ ½ÃÀå¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Ç×ü Á¦Á¶ ½ÃÀå¿¡¼­µµ È®»êµÇ°í ÀÖÀ¸¸ç, °³¹ß¾÷ü°¡ Ç×ü Á¦Á¶ ¾÷¹«¸¦ À§Å¹ÇÏ´Â »ç·Ê°¡ ´Ã°í ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÌ·¯ÇÑ Á¦3ÀÚ ¼­ºñ½º Á¦°ø¾÷üÀÇ ´Ù¾çÇÑ Àü¹® Áö½ÄÀÌ Àüü Á¦Á¶ ºñ¿ë Àý°¨ µî ´Ù¾çÇÑ ÀÌÁ¡À» Á¦°øÇÏ´Â °á°úÀÔ´Ï´Ù. ¶ÇÇÑ, »ý¹°Á¦Á¦¸¦ ÀÚüÀûÀ¸·Î Á¦Á¶Çϱâ À§ÇÑ ½Ã¼³ÀÇ ¼³°è, °Ç¼³, À¯Áö°ü¸® µî ÇÊ¿äÇÑ Àü¹®Áö½Ä°ú ´É·ÂÀ» °®Ãß±â À§Çؼ­´Â »ó´çÇÑ ¼³ºñÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó Á¦¾à¾÷°èÀÇ ¸¹Àº Áß¼Ò±â¾÷°ú ¶§·Î´Â ´ëÇü Á¦¾à»çµéµµ Á¦Á¶ ¾÷¹«ÀÇ ¾Æ¿ô¼Ò½ÌÀ» ½ÃÀÛÇÏ¿´½À´Ï´Ù.

Antibody Contract Manufacturing Market-IMG1

»ý¹°ÇÐÀû Á¦Á¦ ¹× Ç×ü Á¦Á¶¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±â¼ú ¹ßÀü, ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡ µî ´Ù¾çÇÑ ¿äÀο¡ ÈûÀÔ¾î Ç×ü À§Å¹»ý»ê ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ç×ü À§Å¹»ý»ê ½ÃÀå ÁÖ¿ä ÀλçÀÌÆ®

º» º¸°í¼­¿¡¼­´Â Ç×ü À§Å¹»ý»ê ½ÃÀåÀÇ ÇöȲÀ» Á¶»çÇϰí, ¾÷°èÀÇ ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÕ´Ï´Ù. ÁÖ¿ä Á¶»ç °á°ú´Â ´ÙÀ½°ú °°½À´Ï´Ù.

Antibody Contract Manufacturing Market-IMG2
Antibody Contract Manufacturing Market-IMG3
Antibody Contract Manufacturing Market-IMG4

Ç×ü À§Å¹»ý»ê ½ÃÀå ÁÖ¿ä ºÎ¹®

»ý»êµÇ´Â Ç×ü À¯Çüº°·Î º¸¸é, ½ÃÀåÀº ´ÜÀÏŬ·ÐÇ×ü¿Í ÀÌÁß Æ¯À̼º Ç×ü·Î ºÐ»êµÇ¾î ÀÖ½À´Ï´Ù. ÇöÀç, ´ÜÀÏŬ·ÐÇ×ü ºÎ¹®Àº Àü ¼¼°è Ç×ü À§Å¹»ý»ê ½ÃÀåÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÇÏÁö¸¸, ÁøÃâ±â¾÷µéÀº Ä¡·á ¸ñÀûÀÇ ÀÌÁß Æ¯À̼º Ç×ü °³¹ß¿¡µµ ÈûÀ» ½ñ°í ÀÖ½À´Ï´Ù.

»ç¿ëµÇ´Â ¹ßÇö ½Ã½ºÅÛÀÇ À¯Çü·Î º¼ ¶§, ½ÃÀåÀº Æ÷À¯·ù ¹ßÇö ½Ã½ºÅÛ°ú ¹Ì»ý¹° ¹ßÇö ½Ã½ºÅÛÀ¸·Î ºÐ»êµÇ¾î ÀÖ½À´Ï´Ù. ÇöÀç Æ÷À¯·ù ¹ßÇö ½Ã½ºÅÛÀÌ ¼¼°è Ç×ü À§Å¹»ý»ê ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ºñÀ²À» Â÷ÁöÇÏ´Â ÀÌÀ¯´Â Æ÷À¯·ù ¹ßÇö ½Ã½ºÅÛÀ» ÅëÇØ Ç×ü°¡ ´õ ³ôÀº »ý¹°ÇÐÀû Ȱ¼º°ú °áÇÕ Ä£È­¼ºÀ» ´Þ¼ºÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.

»ç¾÷ ±Ô¸ðÀÇ °üÁ¡¿¡¼­ º¼ ¶§, ½ÃÀåÀº ÀÓ»ó ±Ô¸ð¿Í »ó¾÷Àû ±Ô¸ð·Î ºÐ»êµÇ¾î ÀÖ½À´Ï´Ù. ÇöÀç Ç×ü À§Å¹»ý»ê ½ÃÀåÀÇ ´ëºÎºÐÀº Ç×üÀÇ »ó¾÷Àû »ý»ê¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ »ó¾÷Àû ±Ô¸ð°¡ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä Áö¿ªº°·Î ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ºÏ¾ÆÇÁ¸®Ä«¿¡ ºÐ»êµÇ¾î ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â Ç×ü À§Å¹»ý»ê ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿ÃÇØ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾Æ ½ÃÀåÀº ÇâÈÄ ´õ ³ôÀº CAGR·Î ¼ºÀåÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

Ç×ü À§Å¹»ý»ê ½ÃÀå ÁøÃâ±â¾÷ »ç·Ê

Ç×ü À§Å¹»ý»ê ½ÃÀå Á¶»ç ´ë»ó

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °æÁ¦Àû ¹× ±âŸ ÇÁ·ÎÁ§Æ® ƯÀ¯ÀÇ °í·Á»çÇ×

Á¦4Àå ÁÖ¿ä ¿ä¾à

Á¦5Àå ¼­·Ð

Á¦6Àå ½ÃÀå ±¸µµ

Á¦7Àå ±â¾÷ °æÀï·Â ºÐ¼®

Á¦8Àå »ó¼¼ÇÑ ±â¾÷ °³¿ä

Á¦9Àå ±â¾÷ °³¿ä ¸®½ºÆ®

Á¦10Àå »ç·Ê ¿¬±¸ : ÀúºÐÀÚ ¹× °íºÐÀÚ(»ý¹°Á¦Á¦) ¾àÁ¦/Ä¡·á¹ý ºñ±³

Á¦11Àå º¥Ä¡¸¶Å· ºÐ¼®

Á¦12Àå ÆÄÆ®³Ê½Ê ¹× Çù¾÷

Á¦13Àå ÃÖ±Ù È®Àå

Á¦14Àå ´É·Â ºÐ¼®

Á¦15Àå ¼ö¿ä ºÐ¼®

Á¦16Àå ½ÃÀå ¿µÇ⠺м® : ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, ±âȸ, °úÁ¦

Á¦17Àå ¼¼°èÀÇ Ç×ü À§Å¹»ý»ê ½ÃÀå

Á¦18Àå ¼¼°èÀÇ Ç×ü À§Å¹»ý»ê ½ÃÀå(Á¦Á¶µÇ´Â Ç×ü À¯Çüº°)

Á¦19Àå ¼¼°èÀÇ Ç×ü À§Å¹»ý»ê ½ÃÀå(»ç¾÷ ±Ô¸ðº°)

Á¦20Àå ¼¼°èÀÇ Ç×ü À§Å¹»ý»ê ½ÃÀå(»ç¿ëµÇ´Â ¹ßÇö ½Ã½ºÅÛ À¯Çüº°)

Á¦21Àå ¼¼°èÀÇ Ç×ü À§Å¹»ý»ê ½ÃÀå(ÁÖ¿ä Áö¿ªº°)

Á¦22Àå SWOT ºÐ¼®

Á¦23Àå Ç×ü CMO ½ÃÀå Àü¸Á

Á¦24Àå °æ¿µÁø ÀλçÀÌÆ®

Á¦25Àå ºÎ·Ï 2 : Ç¥ µ¥ÀÌÅÍ

Á¦26Àå ºÎ·Ï 3 : ±â¾÷ ¹× ´Üü ¸®½ºÆ®

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Antibody Contract Manufacturing Market: Overview

As per Roots Analysis, the global antibody contract manufacturing market is estimated to grow from USD 18.5 billion in the current year to USD 46.8 billion by 2035, at a CAGR of 9.7% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Antibody Manufactured

Type of Expression System Used

Scale of Operation

Geographical Regions

Antibody Contract Manufacturing Market: Growth and Trends

Antibodies constitute one of the fastest growing drug classes amongst the diverse range of biologics. Over the years, there has been evolution of concepts and methods, which have facilitated several innovative advances in the development and manufacturing of increasingly complex and efficacious antibody-based therapeutics. Despite the fact that biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, these therapeutic products are generally known to be associated with high costs of development and complex manufacturing protocols

In the past few years, contract manufacturers have played a critical role in the overall biopharmaceutical market. This trend has also become prevalent in the antibody manufacturing market, as developers are increasingly outsourcing their antibody manufacturing operations to contract service providers. This is a result of the diverse expertise of such third-party service providers in offering various advantages, including reduction in overall production cost. In addition, acquiring the necessary expertise and capabilities, which includes designing, constructing and maintaining a facility for manufacturing biologics in-house, requires significantly high capital investments. Therefore, many of the smaller players in the industry and, at times, certain pharma giants as well, have begun outsourcing their manufacturing operations to contract service providers.

Antibody Contract Manufacturing Market - IMG1

Driven by a range of factors, including the growing demand for biologics and antibody manufacturing, technological advancements, and increasing investment in research and development, the antibody contract manufacturing market is poised to grow significantly over the coming years.

Antibody Contract Manufacturing Market: Key Insights

The report delves into the current state of the antibody contract manufacturing market and identifies potential growth opportunities within industry. Some key findings from the report include:

Antibody Contract Manufacturing Market - IMG2
Antibody Contract Manufacturing Market - IMG3
Antibody Contract Manufacturing Market - IMG4

Antibody Contract Manufacturing Market: Key Segments

Monoclonal Antibodies Capture the Largest Market Share

In terms of the type of antibody manufactured, the market is distributed across monoclonal and bispecific antibody. At present, the monoclonal antibody segment constitutes the majority share of the global antibody contract manufacturing market. However, players are also intensely focused on the development of bispecific antibodies for therapeutic purposes.

Microbial Expression System is the Fastest Growing Segment

In terms of the type of expression system used, the market is distributed across mammalian and microbial expression systems. Currently, the mammalian expression system segment captures the highest proportion of the global antibody contract manufacturing market given the fact that mammalian expression systems enable antibodies to achieve greater biological activity and binding affinity.

Commercial Scale Segment Occupies the Largest Share

In terms of the scale of operation, the market is distributed across clinical and commercial scale. In the current year, majority of the antibody contract manufacturing market is held by commercial scale owing to the increasing demand for commercial production of antibodies.

North America is Leading the Global Antibody Contract Manufacturing Market

In terms of key geographical regions, the market is distributed across North America, Europe, Asia, Latin America and Middle East and North Africa. North America dominates the antibody contract manufacturing market and accounts for the largest revenue share in the current year. Further, the market in Asia is likely to grow at a higher CAGR in the coming future.

Example Players in the Antibody Contract Manufacturing Market

Antibody Contract Manufacturing Market: Research Coverage

Key Questions Answered in this Report

Reasons to Buy this Report

Additional Benefits

TABLE OF CONTENTS

1. PREFACE

2. RESEARCH METHODOLOGY

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

4. EXECUTIVE SUMMARY

5. INTRODUCTION

6. MARKET LANDSCAPE

7. COMPANY COMPETITIVENESS ANALYSIS

8. DETAILED COMPANY PROFILES

9. TABULATED COMPANY PROFILES

10. CASE STUDY: COMPARISON OF SMALL AND LARGE MOLECULES (BIOLOGICS) DRUGS / THERAPIES

11. BENCHMARK ANALYSIS

12. PARTNERSHIPS AND COLLABORATIONS

13. RECENT EXPANSIONS

14. CAPACITY ANALYSIS

15. DEMAND ANALYSIS

16 MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

17 GLOBAL ANTIBODY CONTRACT MANUFACTURING MARKET

18. GLOBAL ANTIBODY CONTRACT MANUFACTURING MARKET, BY TYPE OF ANTIBODY MANUFCATURED

19. GLOBAL ANTIBODY CONTRACT MANUFACTURING MARKET, BY SCALE OF OPERATION

20. GLOBAL ANTIBODY CONTRACT MANUFACTURING MARKET, BY TYPE OF EXPRESSION SYSTEM USED

21. GLOBAL ANTIBODY CONTRACT MANUFACTURING MARKET, BY KEY GEOGRAPHICAL REGIONS

22. SWOT ANALYSIS

23 FUTURE OF THE ANTIBODY CMO MARKET

24. EXECUTIVE INSIGHTS

25. APPENDIX 2: TABULATED DATA

26. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATIONS

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â